Estrogen attenuates the MPTP-induced loss of dopamine neurons from the mouse SNc despite a lack of estrogen receptors (ERα and ERβ)

Experimental Neurology

Volumn 190, Issue 2, 2004, Pages 468-477

  Shughrue, Paul J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Dopamine; Estradiol; Substantia nigra

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MESSENGER RNA; NEUROTOXIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CELL LOSS; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DRUG EFFECT; EVALUATION; FROZEN SECTION; HYBRIDIZATION; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; INTOXICATION; MALE; MOUSE; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RNA PROBE; SUBSTANTIA NIGRA; TIME SERIES ANALYSIS;

ANIMALS; AUTORADIOGRAPHY; CASTRATION; CORPUS STRIATUM; DOPAMINE; ESTROGENS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MICE; MPTP POISONING; NEURONS; RECEPTORS, ESTROGEN; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 8644262488     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.expneurol.2004.08.009     Document Type: Article

References (38)

1. A. Ascherio, H. Chen, M.A. Schwarzschild, S.M. Zhang, G.A. Colditz, and F.E. Speizer Caffeine, postmenopausal estrogen, and risk of Parkinson's disease Neurology 60 2003 790 795
2. M. Baldereschi, A. Di Carlo, W.A. Rocca, P. Vanni, S. Maggi, E. Perissinotto, F. Grigoletto, L. Amaducci, and D. Inzitari Parkinson's disease and parkinsonism in a longitudinal study. Two-fold higher incidence in men Neurology 55 2000 1358 1363
3. M.D. Benedetti, D.M. Maraganore, J.H. Bower, S.K. McDonnell, B.J. Peterson, J.E. Ahlskog, D.J. Schaid, and W.A. Rocca Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study Mov. Disord. 16 2001 830 837
4. M. Blurton-Jones, and M.H. Tuszynski Reactive astrocytes express estrogen receptors in the injured primate brain J. Comp. Neurol. 433 2001 115 123
5. J.H. Bower, D.M. Maraganore, S.K. McDonnell, and W.A. Rocca Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990 Neurology 52 1999 1214 1220
6. J.H. Bower, D.M. Maraganore, S.K. McDonnell, and W.A. Rocca Influence of strict, intermediate, and broad diagnostic criteria on the age- and sex-specific incidence of Parkinson's disease Mov. Disord. 15 2000 819 825
7. S. Callier, M. Morissette, M. Grandbois, and T. Di Paolo Stereospecific prevention by 17β-estradiol of MPTP-induced dopamine depletion in mice Synapse 37 2000 245 251
8. S. Callier, M. Morissette, M. Grandbois, D. Pelaprat, and T. Di Paolo Neuroprotective properties of 17β-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice Synapse 41 2001 131 138
9. M. D'Astous, M. Morissette, B. Tanguay, S. Callier, and T. Di Paolo Dehydroepiandrosterone (DHEA) such as 17β-estradiol prevents MPTP-induced dopamine depletion in mice Synapse 47 2003 10 14
10. S.G. Diamond, C.H. Markham, M.M. Hoehn, F.H. McDowell, and M.D. Muenter An examination of male-female differences in progression and mortality of Parkinson's disease Neurology 40 1990 763 766
11. D.E. Dluzen, and J.L. McDermott Neuroprotective role of estrogen upon methamphetamine and related neurotoxins within the nigrostriatal dopaminergic system Ann. N. Y. Acad. Sci. 914 2000 112 126
12. D.E. Dluzen, and M.W.I.M. Horstink Estrogen as a neuroprotectant of the nigrostriatal dopaminergic system: laboratory and clinical studies Endocrine 21 2003 67 75
13. D.E. Dluzen, J.L. McDermott, and B. Liu Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/B1 mice Neurotoxicol. Teratol. 18 1996 603 606
14. D.E. Dluzen, J.L. McDermott, and L.I. Anderson Tamoxifen eliminates estrogen's neuroprotective effect upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system Neurotox. Res. 3 2001 291 300
15. D.B. Dubal, M.L. Kashon, L.C. Pettigrew, J.M. Ren, S.P. Finklestein, S.W. Rau, and P.M. Wise Estradiol protects against ischemic injury J. Cereb. Blood Flow. Metab. 18 1998 1253 1258
16. D.B. Dubal, P.J. Shughrue, M.E. Wilson, I. Merchenthaler, and P.M. Wise Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors J. Neurosci. 19 1999 6385 6393
17. D.B. Dubal, H. Zhu, J. Yu, S.W. Rau, P.J. Shughrue, I. Merchenthaler, M.S. Kindy, and P.M. Wise Estrogen receptor α, not β, is a critical link in estradiol-mediated protection against brain injury Proc. Natl. Acad. Sci. U. S. A. 98 2001 1952 1957
18. X. Gao, and D.E. Dluzen Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system Neuroscience 103 2001 385 394
19. M. Grandbois, M. Morissette, S. Callier, and T. Di Paolo Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice NeuroReport 11 2000 343 346
20. T. Jover, H. Tanaka, A. Calderone, K. Oguro, M.V.L. Bennett, A.M. Etgen, and R.S. Zukin Estrogen protects against global ischemic-induced neuronal death and prevents activation of apoptotic signaling cascades in the hippocampal CA1 J. Neurosci. 22 2002 2115 2124
21. M. Koch, and G. Ehret Immunocytochemical localization and quantitation of estrogen-binding cells in the male and female (virgin, pregnant, lactating) mouse brain Brain Res. 489 1989 101 112
22. B. Ky, and P.J. Shughrue Methods to enhance signal using isotopic in situ hybridization J. Histochem. Cytochem. 50 2002 1031 1037
23. I. Merchenthaler, T.L. Dellovade, and P.J. Shughrue Neuroprotection by estrogen in animal models of global and focal ischemia Ann. N. Y. Acad. Sci. 1007 2003 89 100
24. I. Merchenthaler, M.V. Lane, S. Numan, and T.L. Dellovade Distribution of estrogen receptors alpha and beta in the mouse central nervous system: in vivo autoradiographic and immunocytochemical analyses J. Comp. Neurol. 473 2004 270 291
25. S.W. Mitra, E. Hoskin, J. Yudkovitz, L. Pear, H.A. Wilkinson, S. Hayashi, D.W. Pfaff, S. Ogawa, S.P. Rohrer, J.M. Schaeffer, B.S. McEwen, and S.E. Alves Immunolocalization of estrogen receptor β in the mouse brain: comparison with estrogen receptor α Endocrinology 144 2003 2055 2067
26. H.E. Murray, A.V. Pillai, S.R. McArthur, N. Razvi, K.P. Datla, D.T. Dexter, and G.E. Gillies Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females Neuroscience 116 2003 213 222
27. O. Rabbani, K.S. Panickar, G. Rajakumar, M.A. King, N. Bodor, E.M. Meyer, and J.W. Simpkins 17β-estradiol attenuates fimbrial lesion-induced decline of ChAT-immunoreactive neurons in the rat medial septum Exp. Neurol. 146 1997 179 186
28. R.L. Roof, and E.D. Hall Estrogen-related gender difference in survival rate and cortical blood flow after impact-acceleration head injury in rats J. Neurotrauma 17 2000 1155 1169
29. R. Rusa, N.J. Alkayed, B.J. Crain, R.J. Traystman, A.S. Kimes, E.D. London, J.A. Klaus, and P.D. Hurn 17β-estradiol reduces stroke injury in estrogen-deficient female animals Stroke 30 1999 1665 1670
30. P.J. Shughrue, G.R. Askew, T.L. Dellovade, and I. Merchenthaler Estrogen-binding sites and their functional capacity in estrogen receptor double knockout mouse brain Endocrinology 143 2002 1643 1650
31. P.J. Shughrue, M.V. Lane, and I. Merchenthaler The comparative distribution of estrogen receptor-α and β mRNA in the rat central nervous system J. Comp. Neurol. 388 1997 507 525
32. P. Shughrue, P. Scrimo, M.V. Lane, R. Askew, and I. Merchenthaler The distribution of estrogen receptor-β mRNA in forebrain regions of the estrogen receptor-α knockout mouse Endocrinology 138 1997 5649 5652
33. J.W. Simpkins, G. Rajakumar, Y-.Q. Zhang, C.E. Simpkins, D. Greenwald, C.J. Yu, N. Bodor, and A.L. Day Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat J. Neurosurg. 87 1997 724 730
34. 3H-estradiol W.E. Stumpf L.D. Grant Anatomical Neuroendocrinology 1975 Karger Basel 82 103
35. S. Sudo, T-.C. Wen, J. Desaki, S. Matsuda, J. Tanaka, T. Arai, N. Maeda, and M. Sakanaka β-estradiol protects hippocampal CA1 neurons against transient forebrain ischemia in gerbil Neurosci. Res. 29 1997 345 354
36. E. Sundstrom, J. Luthman, M. Goldstein, and G.T.I. Jonsson Time course of MPTP-induced degeneration of the nigrostriatal dopamine system in C57 BL/6 mice Brain Res. Bull. 21 1988 257 263
37. R.E. Watson, S.J. Wiegand, R.W. Clough, and G.E. Hoffman Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology Peptides 7 1986 155 159
38. L. Yu, Y. Kuo, C.G. Cherng, H-.H. Chen, and C-.H. Hsu Ovarian hormones do not attenuate methamphetamine-induced dopamine neurotoxicity in mice gonadectomized at 4 weeks postpartum Neuroendocrinology 75 2002 282 287